JPMorgan Chase & Co’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-172,658
| Closed | -$2.58M | – | 6405 |
|
|
2022
Q4 | $2.58M | Buy |
172,658
+172,558
| +172,558% | +$2.58M | ﹤0.01% | 2803 |
|
|
2022
Q3 | $1K | Buy |
100
+5
| +5% | +$50 | ﹤0.01% | 5487 |
|
|
2022
Q2 | $1K | Hold |
95
| – | – | ﹤0.01% | 5547 |
|
|
2022
Q1 | $1K | Hold |
95
| – | – | ﹤0.01% | 5691 |
|
|
2021
Q4 | $0 | Hold |
95
| – | – | ﹤0.01% | 6217 |
|
|
2021
Q3 | $1K | Hold |
95
| – | – | ﹤0.01% | 5488 |
|
|
2021
Q2 | $1K | Sell |
95
-8,153
| -99% | -$85.8K | ﹤0.01% | 5459 |
|
|
2021
Q1 | $60K | Sell |
8,248
-96,978
| -92% | -$705K | ﹤0.01% | 4763 |
|
|
2020
Q4 | $607K | Buy |
105,226
+59,954
| +132% | +$346K | ﹤0.01% | 3651 |
|
|
2020
Q3 | $262K | Buy |
45,272
+40,696
| +889% | +$236K | ﹤0.01% | 3622 |
|
|
2020
Q2 | $24K | Buy |
+4,576
| New | +$24K | ﹤0.01% | 4387 |
|
|
2019
Q2 | – | Sell |
-2,615
| Closed | -$21K | – | 5024 |
|
|
2019
Q1 | $21K | Sell |
2,615
-123
| -4% | -$988 | ﹤0.01% | 4501 |
|
|
2018
Q4 | $44K | Buy |
2,738
+332
| +14% | +$5.34K | ﹤0.01% | 4314 |
|
|
2018
Q3 | $80K | Buy |
2,406
+342
| +17% | +$11.4K | ﹤0.01% | 4194 |
|
|
2018
Q2 | $47K | Sell |
2,064
-9,328
| -82% | -$212K | ﹤0.01% | 4335 |
|
|
2018
Q1 | $330K | Sell |
11,392
-42,061
| -79% | -$1.22M | ﹤0.01% | 3543 |
|
|
2017
Q4 | $1.49M | Buy |
+53,453
| New | +$1.49M | ﹤0.01% | 2873 |
|
|
2013
Q4 | – | Sell |
-5,488
| Closed | -$113K | – | 3847 |
|
|
2013
Q3 | $113K | Buy |
5,488
+1,168
| +27% | +$24.1K | ﹤0.01% | 3749 |
|
|
2013
Q2 | $109K | Buy |
+4,320
| New | +$109K | ﹤0.01% | 3672 |
|